Protein‐Bound Acrolein

Abstract : Several lines of evidence support the role of oxidative stress, including increased lipid peroxidation, in the pathogenesis of Alzheimer's disease (AD). Lipid peroxidation generates various reactive aldehydes, such as 4‐hydroxynonenal (HNE), which have been detected immunochemically in AD, particularly in neurofibrillary tangels, one of the major diagnostic lesions in AD brains. A recent study demonstrated that acrolein, the most reactive among the α, β‐unsaturated aldehyde products of lipid peroxidation, could be rapidly incorporated into proteins, generating a carbonyl derivative, a marker of oxidative stress to proteins. The current studies used an antibody raised against acrolein‐modified keyhole limpet hemocyanin (KLH) to test whether acrolein modification of proteins occurs in AD. Double immunofluorescence revealed strong acrolein‐KLH immunoreactivity in more than half of all paired helical filament (PHF)‐1‐labeled neurofibrillary tangles in AD cases. Acrolein‐KLH immunoreactivity was also evident in a few neurons lacking PHF‐1‐positive neurofibrillary tangles. Light acrolein‐KLH immunoreactivity occurred in dystrophic neurites surrounding the amyloid‐β core, which itself lacked acrolein‐KLH staining. The pattern of acrolein‐KLH immunostaining was similar to that of HNE. Control brains did not contain any acrolein‐KLH‐immunoreactive structures. The current results suggest that protein‐bound acrolein is a powerful marker of oxidative damage to protein and support the hypothesis that lipid peroxidation and oxidative damage to protein may play a crucial role in the formation of neurofibrillary tangles and to neuronal death in AD.

[1]  E. Niki,et al.  Acrolein Is a Product of Lipid Peroxidation Reaction , 1998, The Journal of Biological Chemistry.

[2]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[3]  E. Niki,et al.  Protein-bound acrolein: potential markers for oxidative stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Smith,et al.  Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. , 1998, The American journal of pathology.

[5]  J. Kehrer,et al.  Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. , 1997, Toxicology.

[6]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Stadtman,et al.  Protein Oxidation in Aging, Disease, and Oxidative Stress* , 1997, The Journal of Biological Chemistry.

[8]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[9]  M. Beal,et al.  Oxidative damage in Alzheimer's , 1996, Nature.

[10]  G. Siest,et al.  Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain , 1996, Neuroscience Letters.

[11]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[12]  E. Stopa,et al.  Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain , 1995, Annals of neurology.

[13]  D. Price,et al.  Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. , 1995, The American journal of pathology.

[14]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[15]  J. Heinecke,et al.  Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. , 1994, The Journal of biological chemistry.

[16]  C. W. Scott,et al.  Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Perry,et al.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.

[18]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[19]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[20]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Stadtman,et al.  Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N. Robakis,et al.  Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .

[23]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Nagano,et al.  Modifications of neurofilament proteins by possible metabolites of allyl chloride in vitro. , 1995, Drug and chemical toxicology.

[26]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[27]  G. Ansari,et al.  In vitro covalent modification of serum albumin by acrolein , 1991 .

[28]  W. D. Ehmann,et al.  Brain trace elements in Alzheimer's disease. , 1986, Neurotoxicology.